InMode (INMD) Non-Current Deferred Tax Liability (2018 - 2019)
InMode (INMD) posted quarterly Non-Current Deferred Tax Liability of $37000.0 for Q4 2019, up 236.36% year-on-year from $11000.0 in Q4 2018, and up 236.36% on a QoQ basis from $11000.0 in Q4 2018.
InMode (INMD) Non-Current Deferred Tax Liability (2018 - 2019) Analysis & Trends
InMode (INMD) has reported Non-Current Deferred Tax Liability for 2 consecutive years, with $37000.0 the latest figure, recorded in Q4 2019.
- Quarterly Non-Current Deferred Tax Liability rose 236.36% year-over-year to $37000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $37000.0 (up 236.36% YoY) and the FY2019 annual result came in at $37000.0, up 236.36% from the prior year.
- Non-Current Deferred Tax Liability advanced to $37000.0 in Q4 2019 per INMD's latest filing, from $11000.0 in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for INMD reached as high as $37000.0 in Q4 2019 and fell as low as $11000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | InMode | 975,741.41 | -479.15 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 37,000.00 |
| Dec 31, 2019 | 37,000.00 |
| Dec 31, 2018 | 11,000.00 |
| Dec 31, 2018 | 11,000.00 |